Cost-effectiveness analysis of immune-modulating nutritional support for gastrointestinal cancer patients

Clinical Nutrition

Volumn 33, Issue 4, 2014, Pages 649-654

  Chevrou Séverac, Hélène ^a   Pinget, Christophe ^b   Cerantola, Yannick ^b   Demartines, Nicolas ^b   Wasserfallen, Jean Blaise ^b   Schäfer, Markus ^b  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cost effectiveness analysis; Gastrointestinal cancer surgery; Immune modulating formula; Post surgical complication risk

Indexed keywords

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; ENTERIC FEEDING; HOSPITAL COST; HOSPITALIZATION; HUMAN; IMMUNE MODULATING NUTRITIONAL FORMULA; LENGTH OF STAY; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PREFORMULATION; SENSITIVITY ANALYSIS; SOCIOECONOMICS; SWITZERLAND; ANALYSIS; CHEMISTRY; COST BENEFIT ANALYSIS; ECONOMICS; ELEMENTAL DIET; GASTROINTESTINAL NEOPLASMS; IMMUNOMODULATION; META ANALYSIS; POSTOPERATIVE PERIOD; SENSITIVITY AND SPECIFICITY; SOLUTION AND SOLUBILITY;

SOLUTION AND SOLUBILITY;

COST-BENEFIT ANALYSIS; FOOD, FORMULATED; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOMODULATION; LENGTH OF STAY; NUTRITIONAL SUPPORT; POSTOPERATIVE PERIOD; SENSITIVITY AND SPECIFICITY; SOLUTIONS; SWITZERLAND;

EID: 84902359968     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.09.001     Document Type: Article

References (19)

1. Braga M., Gianotti L., Vignali A., Schmid A., Nespoli L., Di Carlo V. Hospital resources consumed for surgical morbidity: effects of preoperative arginine and omega-3 fatty acid supplementation on costs. Nutrition 2005 Nov-Dec, 21(11-12):1078-1086.
2. Proctor L.D., Davenport D.L., Bernard A.C., Zwischenberger J.B. General surgical operative duration is associated with increased risk-adjusted infectious complication rates and length of hospital stay. JAm Coll Surg 2010, 210(1). 60-65.e1-2.
3. Waitzberg D.L., Saito H., Plank L.D., Jamieson G.G., Jagannath P., et al. Postsurgical infections are reduced with specialized nutrition support. World J Surg 2006, 30(8):1592-1604.
4. Marik P.E., Zaloga G.P. Immunonutrition in high-risk surgical patients: a systematic review and analysis of the literature. JPEN J Parenter Enteral Nutr 2010, 34(4):378-386.
5. Cerantola Y., Hübner M., Grass F., Demartines N., Schäfer M. Immunonutrition in gastrointestinal surgery. Br J Surg 2011, 98(1):37-48.
6. Drover J.W., Dhaliwal R., Weitzel L., Wischmeyer P.E., Ochoa J.B., Heyland D.K. Perioperative use of arginine-supplemented diets: a systematic review of the evidence. JAm Coll Surg 2011, 212(3). 385-399, 399.e1.
7. Marimuthu K., Varadhan K.K., Ljungqvist O., Lobo D.N. Ameta-analysis of the effect of combinations of immune modulating nutrients on outcome in patients undergoing major open gastrointestinal surgery. Ann Surg 2012, 255:1060-1068.
8. Steiner C., Elixhauser A., Schnaier J. The healthcare cost and utilization project: an overview. Eff Clin Pract 2002, 5(3):143-151.
9. Hübner M., Cerantola Y., Grass F., Coti Bertrand P., Schäfer M., Demartines N. Preoperative immunonutrition in patients at nutritional risk: results of a double-blinded randomized clinical trial. Eur J Clin Nutr 2012, 66(7):850-855.
10. Giger-Pabst U., Lange J., Maurer C., Bucher C., Schreiber V., Schlumpf R., et al. Short-term preoperative supplementation of an immunoenriched diet does not improve clinical outcome in well-nourished patients undergoing abdominal cancer surgery. Nutrition 2013, 29(5):724-729.
11. Zhang Y., Gu Y., Guo T., Li Y., Cai H. Perioperative immunonutrition for gastrointestinal cancer: a systematic review of randomized controlled trials. Surg Oncol 2012, 21(2):e87-e95.
12. Senkal M., Zumtobel V., Bauer K.H., Marpe B., Wolfram G., Frei A., et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 1999, 134(12):1309-1316.
13. Braga M., Gianotti L. Preoperative immunonutrition: cost-benefit analysis. JPEN J Parenter Enteral Nutr 2005, 29(Suppl.1):S57-S61.
14. Mauskopf J., Candrilli S., Chevrou-Séverac H., Ochoa J.B. Immunonutrition for gastrointestinal cancer surgical patients: an effective and cost-savings intervention. World J Surg Oncol 2012, 10:136.
15. Weimann A., Braga M., Harsanyi L., Laviano A., Ljungqvist O., Soeters P. ESPEN Guidelines on Enteral Nutrition for Surgery including organ transplantation. Clin Nutr 2006, 25(2):224-244.
16. Kondrup J., Rasmussen H.H., Hamberg O., Stanga Z. Nutritional Risk Screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003, 22:321-336. an ad hoc ESPEN working group.
17. Value for money in health spending; OECD health policy studies 2010, ISBN: 978-92-64-08880-1 (Print)/ISBN: 978-92-64-08881-8 (PDF)/200 pp.
18. Moore F.A. Effects of immune-enhancing diets on infectious morbidity and multiple organ failure. JPEN J Parenter Enteral Nutr 2001, 25(Suppl.2):S36-SS42.
19. Van Bokhorst-de van der Schueren M.A.E., van Leeuwen P.A.M., Sauerwein H.P., Kuik D.J., Snow G.B., Quak J.J. Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications. Head Neck 1997, 19:419-425.